The Peptide LLTRAGL Derived from Rapana venosa Exerts Protective Effect against Inflammatory Bowel Disease in Zebrafish Model by Regulating Multi-Pathways
Marine Drugs · 2024
DOI: 10.3390/md22030100 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marine Drugs, 2024. Verfasst von Yongna Cao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Biology Institute, Qilu University of Technology (Shandong Academy of Sciences), Jinan 250103, China. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases, Colitis, Perciformes, Snails. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Natural Science Foundation of China, National Key R&D Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Inflammatory bowel disease (IBD) is a chronic inflammatory bowel disease with unknown pathogenesis which has been gradually considered a public health challenge worldwide. Peptides derived from Rapana venosa have been shown to have an anti-inflammatory effect. In this study, peptide LLTRAGL derived from Rapana venosa was prepared by a solid phase synthesis technique. The protective effects of LLTRAGL were studied in a 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced zebrafish colitis model. The underlying mechanisms of LLTRAGL were predicted and validated by transcriptome, real-time quantitative PCR assays and molecular docking. The results showed that LLTRAGL reduced the number of macrophages migrating to the intestine, enhanced the frequency and rate of intestinal peristalsis and improved intestinal inflammatory damage. Furthermore, transcriptome analysis indicated the key pathways (NOD-like receptor signal pathway and necroptosis pathway) that link the underlying protective effects of LLTRAGL’s molecular mechanisms. In addition, the related genes in these pathways exhibited different expressions after TNBS treatment. Finally, molecular docking techniques further verified the RNA-sequencing results. In summary, LLTRAGL exerted protective effects in the model of TNBS-induced colitis zebrafish. Our findings provide valuable information for the future application of LLTRAGL in IBD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biology Institute, Qilu University of Technology (Shandong Academy of Sciences), Jinan 250103, China.
- Engineering Research Center of Zebrafish Models for Human Diseases and Drug Screening of Shandong Province, Jinan 250103, China.
- Research Center for Marine Drugs, State Key Laboratory of Oncogenes and Related Genes, Department of Pharmacy, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China.
ORCID-Profile: Houwen Lin
Förderung
- the Natural Science Foundation of China
- National Key R&D Program of China
- National Natural Science Foundation of China
- Taishan Scholars Program
- Jinan Talent Project for University
- Industry Integration Innovation Pilot Project-Basic Research Project of Qilu University of Technology (Shandong Academy of Sciences)
Zitieren
APA
Cao, Y., Xu, F., Xia, Q., Liu, K., Lin, H., Zhang, S., & Zhang, Y. (2024). The Peptide LLTRAGL Derived from Rapana venosa Exerts Protective Effect against Inflammatory Bowel Disease in Zebrafish Model by Regulating Multi-Pathways. Marine Drugs. https://doi.org/10.3390/md22030100
Vancouver
Cao Y, Xu F, Xia Q, Liu K, Lin H, Zhang S, et al. The Peptide LLTRAGL Derived from Rapana venosa Exerts Protective Effect against Inflammatory Bowel Disease in Zebrafish Model by Regulating Multi-Pathways. Marine Drugs. 2024. doi:10.3390/md22030100
BibTeX
@article{Cao2024,
author = {Cao, Yongna and Xu, Fenghua and Xia, Qing and Liu, Kechun and Lin, Houwen and Zhang, Shanshan and Zhang, Yun},
title = {The Peptide LLTRAGL Derived from Rapana venosa Exerts Protective Effect against Inflammatory Bowel Disease in Zebrafish Model by Regulating Multi-Pathways},
journal = {Marine Drugs},
year = {2024},
doi = {10.3390/md22030100}
}
EUVIMED